These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 636499)
1. [Hemodynamic parameters and plasma-renin activity following intravenous dihydralazine administration--a contribution to the regulation of renin]. Börner H; Teichmann G Z Gesamte Inn Med; 1978 Jan; 33(2):44-8. PubMed ID: 636499 [TBL] [Abstract][Full Text] [Related]
2. Effective renal plasma flow (ERPF) of the individual kidney and renal venous renin activity (RVRA) determined simultaneoulsy before and after the administration of dihydralazine in renovascular hypertension. Norman N; Sundsfjord JA; Stiris G Scand J Clin Lab Invest; 1975 May; 35(3):219-29. PubMed ID: 1153919 [TBL] [Abstract][Full Text] [Related]
3. [Arterial hypertension in patients on chronic hemodialysis]. Zogović J; Mladenović Lj Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857 [TBL] [Abstract][Full Text] [Related]
4. [Comparative hemodynamic effects of 2 vasodilators: dihydralazine and diltiazem in permanent essential arterial hypertension]. Levenson J; Simon A; Achimastos A; Temmar M; Safar M Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():167-70. PubMed ID: 6810821 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)]. Ebel H; Lübke H; Klaus D; Zehner J; Witzgall H Dtsch Med Wochenschr; 1978 Oct; 103(42):1650-5. PubMed ID: 699788 [TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of dihydralazine and prazosin in hypertensive patients on the diuretic-reserpine regimen. Salmela PI; Jounela AJ; Karppanen H Ann Clin Res; 1981 Dec; 13(6):433-8. PubMed ID: 6753709 [No Abstract] [Full Text] [Related]
7. [Combined use of dihydralazine and nitroglycerin during and after cardiac surgery (author's transl)]. Brinkmann HM; Krier C; Fleischer F; Dressler P; Späth J Anasth Intensivther Notfallmed; 1982 Feb; 17(1):15-20. PubMed ID: 6802018 [TBL] [Abstract][Full Text] [Related]
8. [Clinical experience with intravenous depressan ampules]. Hennig D Z Urol Nephrol; 1975 Mar; 68(3):169-72. PubMed ID: 1227186 [No Abstract] [Full Text] [Related]
9. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension. Valvo E; Gammaro L; Bedogna V; Tonon M; Giorgetti P; Pica B; Antonini P; Tessitore N; Oldrizzi L; Rugiu C Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196 [TBL] [Abstract][Full Text] [Related]
10. [Functional relationships between plasma renin activity and hemodynamic indices in essential arterial hypertension]. Maugeri Saccà C; Zoccali C; Cerrai T; Mallamaci F; Delfino D; De Vito M Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2446-52. PubMed ID: 7008811 [TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and plasma renin effects of propranolol in essential hypertension. Mookherjee S; Eich RH; Obeid AI; Smulyan H Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147 [TBL] [Abstract][Full Text] [Related]
12. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside]. Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983 [TBL] [Abstract][Full Text] [Related]
13. [Hemodynamic effects and effects on plasma renin activity of injectable acebutolol in arterial hypertension]. Lekieffre J; Carré A; Ginestet A; Dewailly P; Warembourg H Nouv Presse Med; 1975 Dec; 4(46 Suppl):3247-51. PubMed ID: 768906 [TBL] [Abstract][Full Text] [Related]
14. Comparative study on the short-term effects of angiotensin converting enzyme inhibitors (Lopirin, SQUIBB and Tensiomin), and dihydralazine in chronic cardiac failure. Dékány M; Bányai F; Antalóczy Z Acta Physiol Hung; 1988; 72 Suppl():93-110. PubMed ID: 3075406 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of oxdralazine and dihydralazine in essential hypertension. Salvadeo A; Villa G; Segagni S; Piazza W; Criscuolo D Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):372-6. PubMed ID: 7030978 [TBL] [Abstract][Full Text] [Related]
16. Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension. Chobanian AV; Gavras H; Melby JC; Gavras I; Jick H Trans Assoc Am Physicians; 1978; 91():368-80. PubMed ID: 754399 [TBL] [Abstract][Full Text] [Related]
17. Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension. Thibonnier M; Lardoux MD; Corvol P Br J Clin Pharmacol; 1980 Jun; 9(6):561-7. PubMed ID: 6992823 [TBL] [Abstract][Full Text] [Related]
18. [An example of an acceptable combination in the treatment of arterial hypertension]. Menard J; Plouin PF; Gouin F; Corvol P; Milliez P Sem Hop; 1978 Feb; 54(4):201-6. PubMed ID: 208167 [No Abstract] [Full Text] [Related]
19. Interactions of dihydralazine with furosemide in hypertonic patients. Siegmund W; Kairies M; Franke G; Donner I; Biebler KE Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):148-51. PubMed ID: 3557742 [TBL] [Abstract][Full Text] [Related]
20. The kidney and essential hypertension. Balsano F Ann Ital Med Int; 1991; 6(1 Pt 2):93-106. PubMed ID: 1835873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]